Literature DB >> 35834624

Dietary nitrate supplementation and small muscle mass exercise hemodynamics in patients with essential hypertension.

Ryan M Broxterman1,2,3, D Taylor La Salle4, Jia Zhao2, Van R Reese2, Oh Sung Kwon5,6, Russell S Richardson1,2,3,4, Joel D Trinity1,2,3,4.   

Abstract

Exaggerated blood pressure and diminished limb hemodynamics during exercise in patients with hypertension often are not resolved by antihypertensive medications. We hypothesized that, independent of antihypertensive medication status, dietary nitrate supplementation would increase limb blood flow, decrease mean arterial pressure (MAP), and increase limb vascular conductance during exercise in patients with hypertension. Patients with hypertension either abstained from (n = 14, Off-Meds) or continued (n = 12, On-Meds) antihypertensive medications. Within each group, patients consumed (crossover design) nitrate-rich or nitrate-depleted (placebo) beetroot juice for 3 days before performing handgrip (HG) and knee-extensor exercise (KE). Blood flow and MAP were measured using Doppler ultrasound and an automated monitor, respectively. Dietary nitrate increased plasma-[nitrite] Off-Meds and On-Meds. There were no significant effects of dietary nitrate on blood flow, MAP, or vascular conductance during HG in Off-Meds or On-Meds. For KE, dietary nitrate decreased MAP (means ± SD across all 3 exercise intensities, 118 ± 14 vs. 122 ± 14 mmHg, P = 0.024) and increased vascular conductance (26.2 ± 6.1 vs. 24.7 ± 7.0 mL/min/mmHg, P = 0.024), but did not affect blood flow for Off-Meds, with no effects On-Meds. Dietary nitrate-induced changes in blood flow (r = -0.67, P < 0.001), MAP (r = -0.43, P = 0.009), and vascular conductance (r = -0.64, P < 0.001) during KE, but only vascular conductance (r = -0.35, P = 0.039) during HG, were significantly related to the magnitude of placebo values, with no differentiation between groups. Thus, the effects of dietary nitrate on limb hemodynamics and MAP during exercise in patients with hypertension are dependent on the values at baseline, independent of antihypertensive medication status, and dependent on whether exercise was performed by the forearm or quadriceps.NEW & NOTEWORTHY Adverse hemodynamic responses to exercise in patients with hypertension, despite antihypertensive medication, indicate a sustained cardiovascular risk. The efficacy of dietary nitrate to improve limb vascular conductance during exercise was inversely dependent on the magnitude of exercising limb vascular conductance at baseline, rather than antihypertensive medication status. The effects of dietary nitrate on hemodynamics during exercise in patients with hypertension are dependent on the values at baseline and independent of antihypertensive medication status.

Entities:  

Keywords:  beetroot; blood flow; blood pressure; exercise; vascular conductance

Mesh:

Substances:

Year:  2022        PMID: 35834624      PMCID: PMC9377785          DOI: 10.1152/japplphysiol.00218.2022

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  61 in total

1.  Nitrate supplementation enhances the contractile properties of human skeletal muscle.

Authors:  Georg Haider; Jonathan P Folland
Journal:  Med Sci Sports Exerc       Date:  2014-12       Impact factor: 5.411

2.  Inorganic nitrate supplementation enhances functional capacity and lower-limb microvascular reactivity in patients with peripheral artery disease.

Authors:  Joshua M Bock; David P Treichler; Samuel L Norton; Kenichi Ueda; William E Hughes; Darren P Casey
Journal:  Nitric Oxide       Date:  2018-08-15       Impact factor: 4.427

3.  Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1995-02-18

Review 4.  Potential benefits of dietary nitrate ingestion in healthy and clinical populations: A brief review.

Authors:  Sinead T J McDonagh; Lee J Wylie; Christopher Thompson; Anni Vanhatalo; Andrew M Jones
Journal:  Eur J Sport Sci       Date:  2018-03-13       Impact factor: 4.050

Review 5.  Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?

Authors:  John Pernow; Christian Jung
Journal:  Cardiovasc Res       Date:  2013-02-14       Impact factor: 10.787

6.  Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.

Authors:  Kenyatta Cosby; Kristine S Partovi; Jack H Crawford; Rakesh P Patel; Christopher D Reiter; Sabrina Martyr; Benjamin K Yang; Myron A Waclawiw; Gloria Zalos; Xiuli Xu; Kris T Huang; Howard Shields; Daniel B Kim-Shapiro; Alan N Schechter; Richard O Cannon; Mark T Gladwin
Journal:  Nat Med       Date:  2003-11-02       Impact factor: 53.440

7.  Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.

Authors:  Suborno M Ghosh; Vikas Kapil; Isabel Fuentes-Calvo; Kristen J Bubb; Vanessa Pearl; Alexandra B Milsom; Rayomand Khambata; Sheiva Maleki-Toyserkani; Mubeen Yousuf; Nigel Benjamin; Andrew J Webb; Mark J Caulfield; Adrian J Hobbs; Amrita Ahluwalia
Journal:  Hypertension       Date:  2013-04-15       Impact factor: 10.190

Review 8.  Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases.

Authors:  Claudio Napoli; Louis J Ignarro
Journal:  Arch Pharm Res       Date:  2009-08-29       Impact factor: 4.946

9.  Vasodilation to acetylcholine in primary and secondary forms of human hypertension.

Authors:  S Taddei; A Virdis; P Mattei; A Salvetti
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

10.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.